The LRRK2 gene, also known as leucine-rich repeat kinase 2, dardarin, and PARK8, is known for encoding a protein kinase involved in a variety of biological and enzymatic functions. Structurally, the LRRK2 protein is complex, with several distinct domains, including the armadillo repeat (ARM), ankyrin repeat (ANK), leucine-rich repeat (LRR) domain, kinase domain, RAS domain, GTPase domain, and WD40 domain. This structural diversity enables LRRK2 to interact with a variety of cellular components and affect a variety of cellular processes. The protein is primarily located in the cytoplasm but is also associated with the outer mitochondrial membrane, playing a crucial role in maintaining cellular function and integrity.
One of the most important aspects of LRRK2 is its association with Parkinson's disease (PD). Mutations in the LRRK2 gene, particularly the Gly2019Ser mutation, are associated with an increased risk of developing Parkinson's disease. This mutation enhances the kinase activity of the LRRK2 protein, leading to neurodegenerative changes that are characteristic of PD. Notably, the Gly2019Ser mutation is one of the most common genetic causes of Parkinson's disease and is particularly prevalent in certain ethnic groups, such as Ashkenazi Jews and North African Berbers. Additionally, the LRRK2 gene has been linked to other diseases, such as Crohn's disease. Understanding the function of LRRK2 and the impact of its mutations could help pave the way for the development of targeted therapies and treatments for diseases like Parkinson's disease.
Leucine-rich repeat kinase 2 (LRRK2) has been implicated in the vulnerability of dopaminergic neurons to oxidative stress (OS), mitochondrial damage, and increased cell death in idiopathic and familial Parkinson's disease (PD). Here, LRRK2 knockout (KO) HEK-293 cells were used to assess the cellular response to the mitochondrial inhibitor complex I, rotenone (ROT), a well-known inducer of OS and cell death. The study found that exposure of HEK-293 LRRK2 WT cells to rotenone (ROT) resulted in a significant increase in intracellular reactive oxygen species (ROS); enhanced expression of tumor protein (TP53), p53 upregulated modulator of apoptosis (PUMA), and Parkin (PRKN); activation of caspase 3 (CASP3), DNA fragmentation and decreased mitochondrial membrane potential and PTEN induced putative kinase 1 (PINK1) when compared to untreated cells. Translocation of the cytoplasmic fission protein dynamin-related protein 1 (DRP1) to mitochondria was also observed by colocalization with translocase of outer membrane 20 (TOM20). Notably, HEK-293 LRRK2 KO cells treated with ROT showed unchanged OS and apoptotic markers. It was concluded that loss of LRRK2 renders HEK-293 resistant to ROT-induced OS, mitochondrial damage, and apoptosis in vitro. These observations suggest that LRRK2 is an important kinase in the pathogenesis of PD.
To determine whether ROT induced apoptosis in both WT and KO cells, cells were exposed to ROT. ROT increased the activation of p-Ser65-cJUN (Figure 1A,C), TP53 (Figure 1D,F), PUMA (Figure 1G,I), and CASP3 (Figure 1J,L) by +171%, +2000%, +1950%, and +8000%, respectively, in HEK-293 LRRK2 WT cells compared to untreated WT cells. However, ROT did not induce appreciable expression of apoptotic markers in LRRK2 KO cells compared to untreated KO cells (Figure 1B,C,E,F,H,I,K,L). Similar observations were revealed by fluorescent microscopy (FM).
Figure 1. LRRK2 KO induces no activation of pro-apoptosis proteins under ROT stimuli. (Quintero-Espinosa D A, et al. 2023)
Applications of Human LRRK2 Knockout Cell Line-HEK293T
Neurodegenerative Disease Research: The Human LRRK2 Knockout Cell Line-HEK293T is extensively used in the study of neurodegenerative diseases, particularly Parkinson’s Disease. LRRK2 mutations are linked to both familial and sporadic forms of Parkinson’s disease. Knockout cell lines help researchers understand the underlying molecular mechanisms by studying the effects of LRRK2 deficiency.
Drug Screening and Development: This cell line serves as a crucial model for high-throughput screening and development of therapeutic compounds. By comparing the effects of various drugs on LRRK2 knockout versus wild-type HEK293T cells, researchers can identify potential treatments that target specific pathways influenced by LRRK2.
Cell Signaling Studies: LRRK2 is a kinase involved in numerous signaling pathways. Using the LRRK2 knockout HEK293T cell line allows scientists to dissect the role of LRRK2 in signaling cascades, understanding its impact on cellular processes such as autophagy, inflammation, and immune response.
Protein Interaction Analysis: Researchers use this knockout cell line to investigate protein-protein interactions involving LRRK2. This is pivotal in identifying interaction partners and understanding the functional consequences of these interactions in the context of cellular physiology and pathology.
Customer Q&As
What is the recommended growth medium? Does it require antibiotic selection?
A: DMEM supplemented with 10% fetal bovine serum.
It is not required to add the selection antibiotics when culturing the KO cells.
How is the knockout cell line validated?
A: The knockout cell product is validated by PCR amplification and Sanger Sequencing to confirm the mutation at the genomic level. Please find the detailed mutation info in the datasheet.
Is the product a single clonal cell or mixed cell pool?
A: Single clonal cell.
Can I confirm gene knockout by RT-qPCR?
A: No. This knockout cell product is generated using the CRISPR/Cas9 system to induce small insertions or deletions (indels) resulting in frameshift mutations. Although these frameshift mutations typically disrupt the coding gene, there is a possibility that the non-functional transcript may still be transcribed. Consequently, this could potentially yield misleading results when analyzed by RT-qPCR.
How can I store the cell product?
A: The cell line should be stored in liquid nitrogen for long-term preservation.
Is it possible to get multiple knockout clones for my GOI?
A: For most cases, we often keep at least 2 clones with different frameshift mutations. Please feel free to contact us to check if there are additional available clones.
Ask a Question
Customer Reviews
Consistent Results
As a neurodegenerative disease researcher, having reliable cell lines is crucial for my work. The Human LRRK2 Knockout Cell Line-HEK293T has consistently produced reproducible results, significantly enhancing the validity of my experimental data.
Facilitating our research"
The LRRK2 Knockout HEK293T cells have been instrumental in our drug screening assays. The precise knockout of the LRRK2 gene allows us to better understand its role and screen for potential therapeutic compounds.
Write a Review